 Bruce McCollister
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Salmonella typhimurium | 5 | 2016 | 193 | 1.010 |
Why?
| | Salmonella Infections | 4 | 2026 | 58 | 0.770 |
Why?
| | Anti-Bacterial Agents | 9 | 2026 | 1940 | 0.770 |
Why?
| | Nitric Oxide | 5 | 2011 | 892 | 0.540 |
Why?
| | Bacterial Proteins | 7 | 2026 | 976 | 0.490 |
Why?
| | Ceftriaxone | 1 | 2016 | 21 | 0.490 |
Why?
| | beta-Lactamases | 1 | 2016 | 54 | 0.480 |
Why?
| | Bacteremia | 2 | 2016 | 222 | 0.470 |
Why?
| | Escherichia coli Proteins | 1 | 2016 | 201 | 0.430 |
Why?
| | Macrophages | 3 | 2007 | 1529 | 0.420 |
Why?
| | Aminoglycosides | 1 | 2011 | 30 | 0.330 |
Why?
| | Biological Transport | 1 | 2011 | 425 | 0.300 |
Why?
| | Salmonella enterica | 2 | 2007 | 52 | 0.280 |
Why?
| | Interferon-gamma | 3 | 2008 | 786 | 0.260 |
Why?
| | Nitrogen Oxides | 1 | 2007 | 46 | 0.260 |
Why?
| | Sphingomyelin Phosphodiesterase | 1 | 2007 | 27 | 0.260 |
Why?
| | Microbial Viability | 1 | 2007 | 83 | 0.250 |
Why?
| | Meningitis, Cryptococcal | 2 | 2018 | 34 | 0.250 |
Why?
| | Macrophage Activation | 1 | 2007 | 181 | 0.240 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2023 | 251 | 0.240 |
Why?
| | Abscess | 3 | 2015 | 77 | 0.230 |
Why?
| | Gastrointestinal Microbiome | 2 | 2025 | 773 | 0.230 |
Why?
| | Salmonella | 1 | 2026 | 51 | 0.230 |
Why?
| | Phagosomes | 1 | 2005 | 40 | 0.230 |
Why?
| | Membrane Proteins | 3 | 2007 | 1171 | 0.220 |
Why?
| | Skin Diseases, Bacterial | 2 | 2016 | 22 | 0.220 |
Why?
| | Skin Diseases | 2 | 2015 | 152 | 0.190 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2005 | 337 | 0.190 |
Why?
| | Pneumonia, Bacterial | 1 | 2023 | 115 | 0.180 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2025 | 415 | 0.170 |
Why?
| | Microbial Sensitivity Tests | 2 | 2026 | 367 | 0.160 |
Why?
| | Treatment Failure | 2 | 2016 | 360 | 0.140 |
Why?
| | Staphylococcal Infections | 2 | 2015 | 395 | 0.130 |
Why?
| | Cryptococcosis | 1 | 2018 | 31 | 0.130 |
Why?
| | Prophages | 1 | 2016 | 8 | 0.120 |
Why?
| | Ciprofloxacin | 1 | 2016 | 31 | 0.120 |
Why?
| | Antigens, Fungal | 1 | 2016 | 28 | 0.120 |
Why?
| | Sepsis | 1 | 2023 | 671 | 0.120 |
Why?
| | Cryptococcus | 1 | 2016 | 16 | 0.120 |
Why?
| | Pelvic Infection | 1 | 2016 | 6 | 0.120 |
Why?
| | Staphylococcus aureus | 2 | 2011 | 458 | 0.120 |
Why?
| | Tissue Adhesives | 1 | 2016 | 21 | 0.120 |
Why?
| | Hospitalization | 3 | 2016 | 2496 | 0.120 |
Why?
| | Air Filters | 1 | 2015 | 3 | 0.120 |
Why?
| | Genome, Bacterial | 1 | 2016 | 123 | 0.120 |
Why?
| | Gelatin | 1 | 2016 | 56 | 0.110 |
Why?
| | Plasmids | 1 | 2016 | 373 | 0.110 |
Why?
| | Polyurethanes | 1 | 2015 | 38 | 0.110 |
Why?
| | Escherichia coli | 2 | 2016 | 836 | 0.110 |
Why?
| | Mice | 8 | 2026 | 18491 | 0.110 |
Why?
| | Hysterectomy | 1 | 2016 | 138 | 0.110 |
Why?
| | Thrombin | 1 | 2016 | 174 | 0.110 |
Why?
| | Drug Users | 1 | 2015 | 43 | 0.110 |
Why?
| | Reactive Oxygen Species | 2 | 2008 | 616 | 0.110 |
Why?
| | Cellulitis | 1 | 2014 | 54 | 0.100 |
Why?
| | Substance Abuse, Intravenous | 1 | 2015 | 131 | 0.100 |
Why?
| | Mice, Knockout | 3 | 2008 | 3153 | 0.080 |
Why?
| | Animals | 9 | 2026 | 38410 | 0.080 |
Why?
| | Ambulatory Care | 1 | 2016 | 625 | 0.080 |
Why?
| | Nitric Oxide Synthase Type II | 2 | 2008 | 162 | 0.080 |
Why?
| | Enterotoxins | 1 | 1990 | 89 | 0.080 |
Why?
| | NADPH Oxidases | 2 | 2008 | 123 | 0.080 |
Why?
| | HIV Infections | 1 | 2025 | 3235 | 0.070 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2016 | 2223 | 0.070 |
Why?
| | Aged | 6 | 2023 | 26514 | 0.070 |
Why?
| | NADPH Dehydrogenase | 1 | 2008 | 6 | 0.070 |
Why?
| | Respiratory Burst | 1 | 2008 | 19 | 0.070 |
Why?
| | Flavoproteins | 1 | 2007 | 8 | 0.070 |
Why?
| | Hemeproteins | 1 | 2007 | 8 | 0.070 |
Why?
| | Peroxiredoxins | 1 | 2008 | 25 | 0.070 |
Why?
| | Shock, Septic | 1 | 1990 | 230 | 0.070 |
Why?
| | Pseudomonas aeruginosa | 1 | 2011 | 397 | 0.070 |
Why?
| | Salmonella Infections, Animal | 1 | 2008 | 39 | 0.070 |
Why?
| | Macrophages, Peritoneal | 1 | 2008 | 89 | 0.070 |
Why?
| | Gangliosides | 1 | 2007 | 23 | 0.060 |
Why?
| | Succinate Dehydrogenase | 1 | 2007 | 65 | 0.060 |
Why?
| | Mice, Mutant Strains | 1 | 2007 | 303 | 0.060 |
Why?
| | Phagocytes | 1 | 2007 | 80 | 0.060 |
Why?
| | Gastric Mucosa | 1 | 2007 | 54 | 0.060 |
Why?
| | Sphingolipids | 1 | 2007 | 83 | 0.060 |
Why?
| | Cytosol | 1 | 2007 | 213 | 0.060 |
Why?
| | Ceramides | 1 | 2007 | 117 | 0.060 |
Why?
| | Mice, Inbred C57BL | 2 | 2007 | 6041 | 0.060 |
Why?
| | Cross Infection | 1 | 2009 | 261 | 0.060 |
Why?
| | Diabetes Mellitus | 1 | 2014 | 1107 | 0.060 |
Why?
| | Humans | 13 | 2026 | 147293 | 0.050 |
Why?
| | Practice Patterns, Physicians' | 1 | 2014 | 1379 | 0.050 |
Why?
| | DNA, Complementary | 1 | 2005 | 273 | 0.050 |
Why?
| | Microscopy, Electron | 1 | 2005 | 417 | 0.050 |
Why?
| | Immunologic Memory | 1 | 2007 | 370 | 0.050 |
Why?
| | Triazoles | 1 | 2026 | 191 | 0.050 |
Why?
| | RNA, Bacterial | 1 | 2005 | 182 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2026 | 4604 | 0.050 |
Why?
| | Cathelicidins | 1 | 2023 | 40 | 0.050 |
Why?
| | Microscopy, Fluorescence | 1 | 2005 | 409 | 0.050 |
Why?
| | Risk Factors | 5 | 2018 | 11017 | 0.050 |
Why?
| | Oligosaccharides | 1 | 2023 | 61 | 0.050 |
Why?
| | Female | 8 | 2025 | 80076 | 0.050 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2023 | 81 | 0.050 |
Why?
| | Polymerase Chain Reaction | 1 | 2005 | 1046 | 0.050 |
Why?
| | Transcription Factors | 1 | 2010 | 1747 | 0.040 |
Why?
| | Adult | 7 | 2025 | 41405 | 0.040 |
Why?
| | Retrospective Studies | 6 | 2018 | 17560 | 0.040 |
Why?
| | Virulence | 1 | 2023 | 286 | 0.040 |
Why?
| | Oxidative Stress | 1 | 2008 | 1368 | 0.040 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2007 | 932 | 0.040 |
Why?
| | Community-Acquired Infections | 2 | 2015 | 177 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2018 | 3660 | 0.040 |
Why?
| | Middle Aged | 6 | 2018 | 36821 | 0.040 |
Why?
| | Hyponatremia | 1 | 2018 | 43 | 0.030 |
Why?
| | Bacteria | 1 | 2023 | 769 | 0.030 |
Why?
| | Rats | 1 | 2026 | 5613 | 0.030 |
Why?
| | Hemostasis, Surgical | 1 | 2016 | 25 | 0.030 |
Why?
| | Colony Count, Microbial | 1 | 2016 | 90 | 0.030 |
Why?
| | Hospitals, University | 1 | 2016 | 176 | 0.030 |
Why?
| | Male | 6 | 2025 | 73950 | 0.030 |
Why?
| | Colorado | 2 | 2016 | 4591 | 0.030 |
Why?
| | Health Facilities | 1 | 2015 | 85 | 0.030 |
Why?
| | Immunocompromised Host | 1 | 2016 | 202 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 487 | 0.030 |
Why?
| | Academic Medical Centers | 1 | 2018 | 566 | 0.030 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 185 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1550 | 0.030 |
Why?
| | Hearing Loss | 1 | 2018 | 252 | 0.030 |
Why?
| | Vagina | 1 | 2016 | 206 | 0.020 |
Why?
| | Wound Infection | 1 | 2014 | 60 | 0.020 |
Why?
| | Aged, 80 and over | 2 | 2016 | 8430 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2025 | 6543 | 0.020 |
Why?
| | Logistic Models | 1 | 2018 | 2142 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2133 | 0.020 |
Why?
| | Aging | 1 | 2023 | 1992 | 0.020 |
Why?
| | Pregnancy | 1 | 2025 | 7274 | 0.020 |
Why?
| | Cohort Studies | 2 | 2014 | 6099 | 0.020 |
Why?
| | Lung Diseases | 1 | 2018 | 787 | 0.020 |
Why?
| | Guideline Adherence | 1 | 2015 | 590 | 0.020 |
Why?
| | Prevalence | 1 | 2018 | 2889 | 0.020 |
Why?
| | Infant | 1 | 2025 | 10194 | 0.020 |
Why?
| | Culture Media | 1 | 1990 | 161 | 0.020 |
Why?
| | Immunity | 1 | 2010 | 141 | 0.020 |
Why?
| | Rabbits | 1 | 1990 | 654 | 0.020 |
Why?
| | Young Adult | 2 | 2016 | 14437 | 0.020 |
Why?
| | Hypertension | 1 | 2018 | 1280 | 0.020 |
Why?
| | Molecular Epidemiology | 1 | 2009 | 74 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2954 | 0.020 |
Why?
| | Peroxynitrous Acid | 1 | 2008 | 11 | 0.020 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2008 | 20 | 0.020 |
Why?
| | NADPH Oxidase 2 | 1 | 2008 | 32 | 0.020 |
Why?
| | Drug Resistance, Microbial | 1 | 2008 | 67 | 0.020 |
Why?
| | DNA, Bacterial | 1 | 2009 | 320 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 1598 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2010 | 366 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2010 | 1077 | 0.020 |
Why?
| | Organ Specificity | 1 | 2007 | 310 | 0.010 |
Why?
| | Membrane Glycoproteins | 1 | 2008 | 499 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2016 | 3022 | 0.010 |
Why?
| | Emergency Service, Hospital | 1 | 2015 | 2416 | 0.010 |
Why?
| | United States | 1 | 2018 | 16313 | 0.010 |
Why?
| | Adolescent | 1 | 2016 | 22825 | 0.010 |
Why?
|
|
McCollister's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|